{"url_path":"/sec/acet/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1720580/0001720580-26-000036-index.html","accession_number":"0001720580-26-000036","cik":"0001720580","ticker":"ACET","issuer_name":"Adicet Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1720580/0001720580-26-000036-index.html","primary_entity_key":"0001720580","primary_entity_name":"Adicet Bio, Inc."},"word_count":85,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.\n\nDescription\n\n99.1\n\n[Press Release of Adicet Bio, Inc. dated May 13, 2026, furnished herewith.](acet-ex99_1.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nADICET BIO, INC.\n\nDate: May 13, 2026\n\nBy:\n\n/s/ Nick Harvey\n\nName:\n\nNick Harvey\n\nTitle:\n\nChief Financial Officer"}